Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 377,850 | 0 | 0 | 0 | 144,590 |
| Depreciation Amortization | 531,550 | 0 | 0 | 0 | 583,890 |
| Other Working Capital | -101,430 | 0 | 0 | 0 | -87,820 |
| Other Operating Activity | -68,890 | 0 | 0 | 0 | 73,810 |
| Operating Cash Flow | $739,080 | $0 | $0 | $0 | $714,470 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124,810 | 0 | 0 | 0 | -175,580 |
| Net Acquisitions | -343,380 | 0 | 0 | 0 | -39,790 |
| Other Investing Activity | 348,390 | 0 | 0 | 0 | -42,620 |
| Investing Cash Flow | $-119,800 | $0 | $0 | $0 | $-257,990 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -407,800 | 0 | 0 | 0 | -242,340 |
| Financing Cash Flow | $-407,800 | $0 | $0 | $0 | $-242,340 |
| Exchange Rate Effect | 5,500 | 0 | 0 | 0 | 46,520 |
| Beginning Cash Position | 596,580 | 0 | 0 | 0 | 335,930 |
| End Cash Position | 813,560 | 0 | 0 | 0 | 596,580 |
| Net Cash Flow | $216,980 | $0 | $0 | $0 | $260,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | 739,080 | 0 | 0 | 0 | 714,470 |
| Free Cash Flow | 739,080 | 0 | 0 | 0 | 714,470 |